Critics complain that pharmaceutical research budgets emphasize non-debilitating conditions common in developed countries rather than life-threatening diseases common in developing countries
People answering this criticism have contended that ________.
A) correction of developed country conditions, such as balding, are necessary to stimulate developing country innovations that push global economic growth
B) very small portions of research budgets actually target these non-debilitating conditions
C) by being located almost entirely in developed countries, pharmaceutical companies lack access to locations where they can study diseases such as malaria and sleeping sickness
D) pharmaceutical companies cannot recoup expenses for research on some of the developing country problems, so governmental research centers and nonprofit foundations should handle this research
D
You might also like to view...
It is important for the firm to structure its revenue management program in a way that
A) it is presented simply as a mechanism for extracting maximum revenue. B) revenue increases while improving service along some dimension that is important to customers that pay the highest price. C) profit is maximized. D) all of the above
Which of the following is the most traditional dimension of quality?
A) durability B) reliability C) features D) performance E) conformance